Metraipolis › archive › dc_4f06cba45672
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial — Europe PMC PMID:42166177
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42166177
- DOI
- 10.1093/jbmr/zjag085
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T01:29:34.797Z
- SHA-256 of the archived text
bcc711c2472e204844a1070cfa70471918c875495e8d862c6671443e57a3ccd6- Stable URL of this page
https://metraipolis.com/documento/dc_4f06cba45672
How to cite
Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial — Europe PMC PMID:42166177 — Europe PMC (en), https://europepmc.org/article/MED/42166177 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f06cba45672 (Metraipolis archive dc_4f06cba45672, sha256 bcc711c2472e204844a1070cfa70471918c875495e8d862c6671443e57a3ccd6)
BibTeX
@misc{dc4f06cba45672,
title = {Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial — Europe PMC PMID:42166177},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42166177},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f06cba45672; sha256 bcc711c2472e204844a1070cfa70471918c875495e8d862c6671443e57a3ccd6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42166177. Agents can read the archived copy with the MCP tool read_document.